Millennium Management’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-460,000
Closed -$10M – 6153
2024
Q2
$10M Buy
+460,000
New +$10.3M ﹤0.01% 2076
2022
Q4
– Sell
-50,000
Closed -$1.3M – 6635
2022
Q3
$1.3M Buy
+50,000
New +$1.4M ﹤0.01% 4115

Other funds holding CSTL

Millennium Management's CSTL Position: Q3 2026 in Review

Millennium Management increased its Castle Biosciences (CSTL) stake by 141% in Q3 2026, buying an estimated $8.76M and bringing the position to 495,633 shares worth $17.6M. The position accounts for 0.01% of the portfolio, ranked #1730.

Millennium Management first reported a position in CSTL in Q3 2019 and has held it in 27 quarters since. The position peaked at $32.5M in Q4 2020. 202 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Millennium Management held 495,633 shares of Castle Biosciences worth $17.6M as of Q3 2026.
  • Millennium Management bought 290,264 Castle Biosciences shares in Q3 2026, an estimated $8.76M.
  • Castle Biosciences made up 0.01% of Millennium Management's portfolio in Q3 2026, its #1730 holding.
  • Millennium Management first reported a position in Castle Biosciences in Q3 2019 and has held it in 27 quarters since.
  • Millennium Management's Castle Biosciences position peaked at $32.5M in Q4 2020.
  • 202 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.